What is immunotoxin?

Immunotoxin is a protein made by a person that is designed to attack tumor cells. Immunotoxins specifically target tumor cells, leaving healthy cells in the room, allowing a focused attack on a cancer tumor that can prevent the tumor from spreading or actively reducing the tumor. Leukemia of hairy cells is an example of a condition that can be successfully treated by administration of immunotoxins, and scientists are constantly developing new uses for these specialized proteins.

Immunotoxins are a form of hybrid molecules, mixing material from two different proteins that are not normally interconnected. These combinations are said to be chimeric or fusion proteins, reflecting a mixture of material from different sources. Scientists use the technology of technology to melt the proteins they want to include in immunotoxin, and therefore these fusion proteins are sometimes referred to as "recombinant immunotoxins" .onal antibodies produced in mice. Toxin derived from plants or bacteria is attached to the antibody. When the AntilateKa finds a cell on which it is sensitized, the cell takes the antibody and the toxin is released inside, killing the cell. Immunotoxins use endocytosis, a process used by all cells to selectively receive materials through a cell membrane. Like a wolf in the garment of Sheep Imunotoxin, it causes a cell to think that it is something that the cell wants to absorb.

Recombinant immunotoxins have a large promise of cancer treatment because they can focus on specific cells. Cancer treatment historically required very toxic bombing of the body, in which there is hope that cancer cells will die during treatment. Along the way, many healthy cells are also damaged and patients are complicated, such as compromised immune systems WHICich can make a lengthy recovery process lengthy and unpleasant. In immunotoxins, the patient should not withstand exhaustive side effects of cancer treatment.

challenge in the treatment of immunotoxin restingIt is that treatment must be designed specifically for cancer affecting the patient. Antibodies must be sensitized to specific receptors on cancer cells and designed to avoid unintentionally targeting healthy cells in the body. This requires study to find out which type of cancer has a patient and to find suitable receptors, followed by the patient's work laboratory to create an immunotoxin adapted to the patient's case. After designing, immunotoxin can be introduced into the body of injections to find the way to concern.